Objective: To evaluate the outcomes of surgical treatment for perineal endometriosis (PE) at the National Hospital of Obstetrics and Gynecology.
Methods: A descriptive study was conducted, collecting data from the medical records of patients diagnosed with PE who underwent surgery at the National Hospital of Obstetrics and Gynecology between January 2018 and August 2022. Inclusion criteria comprised patients diagnosed with PE who had undergone surgery, had histopathological confirmation of endometriosis, and whose records contained sufficient information. Patients with systemic diseases and/or histopathological results other than endometriosis were excluded. Pain severity was assessed using the Numerical Rating Scale (NRS, 0–10). Quality of life was evaluated using the SF-36 and classified as poor (0–25), moderate (26–75), or good (76–100).
Results: A total of 48 patients were included in the analysis; the mean age was 31 ± 7.18 years (range, 20–43). The mean BMI was 19.74 ± 2.14 (range, 15.3–26.1), with the majority having a BMI of 18.5 to <23 (77.1%). Postoperatively, wound infection occurred in 3/48 cases, and no major surgical complications were recorded. Before surgery, 43/48 patients had NRS scores ≥4 (89.6%); at three months postoperatively, all 48 patients had NRS scores of 1–3 (100%). During follow-up based on records, 2/48 patients experienced recurrence at the perineum. Regarding quality of life (n=26), the proportion of patients with a “good” SF-36 rating increased from 11.6% before treatment to 84.6% at three months and 92.3% at ≥6 months postoperatively.
Conclusion: Surgical treatment for perineal endometriosis demonstrated clear effectiveness in pain reduction and improvement of quality of life, with a low rate of wound infection and a small recurrence rate.